Plasma-derived therapy a potential coronavirus treatment

On 4 March 2020, Japanese firm Takeda Pharmaceutical Co announced they are working on a plasma-derived therapy to treat high-risk patients infected with COVID-19. They are confident they are close to being one of the first approved treatments against the deadly coronavirus. As the pharmacy network is highly depended upon during this time to answer […]

Informed patients have better outcomes: NDMA contamination alert

The US Food and Drug Administration (FDA) released a statement on 13 September 2019 to alert patients and healthcare professionals of possible contamination of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, in some ranitidine products.  The FDA was first alerted to the contamination by online pharmacy Valisure, who found that the “inherent instability” of the ranitidine […]